21 mar, 2023 · In News
21 mar, 2023
Jan 25, 2023 · Regulatory information
Today, the new Carbonhand® is delivered to the first patients in Sweden, Norway, and Germany. Carbonhand, which was launched at the end of last year, has received high praise from patients and healthcare professionals, and now we can deliver systems that will help people with impaired hand function to be able to carry out daily activities and get back to work.
The previous version of our grip enhancing glove Carbonhand has been available in Sweden, Norway and Germany for the past few years and our distributors have had the opportunity to show and trial the brand-new version of Carbonhand to patients since the launch. The interest has been great and Carbonhand has already been prescribed to several patients in these countries.
We currently have an order backlog of approx. 40 Carbonhand systems with an order value of just over SEK 2 million. The order backlog includes both systems for patients and demonstration equipment with 10 gloves per system. We plan to deliver the ordered systems in the next three months.
"The fact that we are today delivering the first systems of Carbonhand, a medical device that is approved for sale throughout Europe, is possible thanks to the fantastic efforts of Bioservo's competent and committed employees. With the new Carbonhand, we can improve patients' grip function in a completely new intuitive way and at the same time revolutionize care for people with impaired hand function worldwide. The company expects that approximately 150 million patients have impaired hand function, and the assessment is that at least 13% of these would be helped by Carbonhand." Says Petter Bäckgren, CEO at Bioservo.
The grip-strengthening glove Carbonhand from Bioservo gives people with reduced hand function extra strength and endurance in their grip. Sensors in the fingertips register when the user grips an object, the system calculates how much force to add and pulls on artificial tendons that go out into the fingers of the hand and add force to the user's grip. Carbonhand® is classified and approved as a medical device under the European Medical Device Regulation (MDR), and is available in several countries in Europe and Australia.
For more information, please contact
Petter Bäckgren, CEO, Bioservo Technologies AB
Phone: +468 21 17 10
Mikael Wester, Marketing Director, Bioservo Technologies AB
Phone: +468 21 17 10
The information in this press release is such that Bioservo Technologies AB (publ) is obliged to publish in accordance with EU Regulation on Market Abuse (MAR). The information was submitted for publication through the agency of above contact persons for publication on January 25, 2023 at 08:30 a.m. CET.
About Bioservo Technologies
Bioservo Technologies AB (publ) is a world leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy, and efficient. The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health for workers and to improve quality of life for people with reduced muscle strength. Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Stockholm.
FNCA Sweden AB is the company’s Certified Adviser on Nasdaq First North
For more information, please visit www.bioservo.com